(Reuters) – Moderna Inc on Tuesday sought conditional marketing authorization with the European Medicines Agency for use of its COVID-19 vaccine in children in the age-group of 6-11 years. The vaccine...

(Reuters) – Moderna’s COVID-19 vaccine could become the second shot okayed for adolescent use in the European Union after regulators on Friday recommended approving it for 12- to 17-year-olds. Use...